STONKWHISPER
← Back to Intel
Insider ActivityMAZE

Bernstein Harold, President, R&D & CMO at Maze Therapeutics, Inc., sold $393K of MAZE

Updated Jun 21, 2026
Bernstein Harold President, R&D & CMO
Maze Therapeutics, Inc. · $MAZE
$393K Total Value
15,000 Shares Traded
$26.2236 Price / Share
Shares Owned After
2026-05-18 Filing Date

Transaction Details

InsiderBernstein Harold
TitlePresident, R&D & CMO
CompanyMaze Therapeutics, Inc.
TickerMAZE
Transaction TypeSale
Transaction Date2026-05-14
Shares Traded15,000
Price Per Share$26.2236
Total Value$393K
Filed Date2026-05-18
Accession Number0002050172-26-000021

Ownership Context

Shares Owned After Transaction
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0002050172-26-000021

Other Insider Trades — MAZE

Other Trades by Bernstein Harold

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for MAZE — Maze Therapeutics, Inc. →

Track MAZE insider activity in real time on The Wire →

Get alerts when Bernstein Harold files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 21, 2026 at 07:13 UTC

Want real-time data? Access The Wire for live sentiment tracking.